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ABSTRACT
The aging of the Canadian population represents the major risk factor for a projected increase in cancer incidence in 
the coming decades. However, the evidence base to guide management of older adults with cancer remains extremely 
limited. It is thus imperative that we develop a national research agenda and establish a national collaborative net-
work to devise joint studies that will help to accelerate the development of high-quality research, education, and 
clinical care and thus better address the needs of older Canadians with cancer. To begin this process, the inaugural 
meeting of the Canadian Network on Aging and Cancer was held in Toronto, 27 April 2016. The meeting was attended 
by 51 invited researchers and clinicians from across Canada, as well as by international leaders in geriatric oncology 
from the United States and France.
The objectives of the meeting were to
 ■ review the present landscape of education, clinical care, and research in the area of cancer and aging in Canada.
 ■ identify issues of high research priority in Canada within the field of cancer and aging.
 ■ identify current barriers to geriatric oncology research in Canada and develop potential solutions.
 ■ develop a Canadian collaborative multidisciplinary research network between investigators to improve health 
outcomes for older adults with cancer.
 ■ learn from successful international efforts to stimulate the geriatric oncology research agenda in Canada.
In the present report, we describe the education, clinical care, and research priorities that were identified at 
the meeting.
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INTRODUCTION
The Canadian population is aging. Adults 65 years of age 
and older will constitute 25% of the Canadian population 
by the year 20361—a fact that is concerning, because cancer 
is a disease associated with aging. Older adults 65 years of 
age and older are 11 times more likely than younger adults 
to develop cancer2. Currently, 60% of all new cancer diag-
noses and 70% of all cancer deaths occur in older adults3,4. 
It is predicted that the cancer incidence will increase by 
79% in the next 15 years, mostly because of the aging of 
the population4.
Despite the aging of the population and the growing 
cancer incidence, there is a paucity of research involving 
older adults with cancer. Older adults, particularly frail 
older individuals with multiple comorbidities, are con-
sistently underrepresented in clinical cancer research, 
comprising only 22% of patients enrolled in ncic trials5, 
despite growing evidence that they are just as likely to 
accept clinical trial enrolment6. That underrepresentation 
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leads to knowledge gaps concerning optimal treatment 
strategies and could contribute to suboptimal care and 
poorer outcomes in older cancer patients7–9. Moreover, 
older adults who are included in a clinical trial tend to be 
highly selected and are thus not representative of the typi-
cal older adult with cancer. It is also important to consider 
how aging can influence the cancer experience for older 
adults, in terms of changes in how older adults perceive 
a diagnosis of cancer and its implications on their health 
and longevity.
Several countries that play a leading role in geriatric 
oncology (for example, the United States, France, and Bel-
gium) have formed national and international networks 
and collaborations that have led to improved clinical 
care, research opportunities, education, and advocacy for 
older adults with cancer. The U.S. research network has 
more than 100 members and formal training programs. In 
France, dedicated geriatric oncology units in each health 
region are organized into one national network. There is 
no equivalent network in Canada. The Canadian Network 
on Aging and Cancer was therefore inaugurated on 27 April 
2016 in Toronto, funded by a Canadian Institutes of Health 
Research meeting and planning grant. Canadian clini-
cians, researchers, educators, allied health care providers, 
and trainees in various disciplines with an interest in geri-
atric oncology, together with international experts from key 
geriatric oncology networks such as the U.S. Cancer and 
Aging Research Group (carg), the International Society 
of Geriatric Oncology, and the French geriatric oncology 
group gerico were invited to attend.
The objectives of the meeting were to
 ■ review the current landscape of education, clinical 
care, and research in the area of cancer and aging in 
Canada.
 ■ identify issues of high research priority in Canada 
within the field of cancer and aging.
 ■ identify current barriers to geriatric oncology research 
in Canada and develop potential solutions.
 ■ develop a collaborative multidisciplinary research net-
work of investigators across Canada who are interested 
in fostering research and improving health outcomes 
for older adults with cancer.
 ■ learn from successful efforts in other countries to stim-
ulate the geriatric oncology research agenda in Canada.
Table I lists the attendees and their affiliations, and 
Table II sets out the agenda of the meeting day. During the 
morning and afternoon sessions, small-group discussions 
about education needs, clinical needs, and research prior-
ities in geriatric oncology were held and are summarized 
later in this article. First, the present state of education, 
clinical care, and research in Canada is described, together 
with short- and long-term priorities (Table III presents an 
overview of all priorities).
SESSION DESCRIPTIONS
Geriatric Oncology Education
The education session was moderated by Drs. Tina Hsu 
and Ewa Szumacher. Attendees agreed that education in 
geriatric oncology for all clinicians and trainees involved in 
caring for older adults with cancer is imperative to help ad-
vance the field and to improve outcomes for older patients. 
However, it was recognized that most trainees in Canada 
receive little to no geriatric oncology training. Currently 
in Canada, geriatric oncology subspecialty training is 
available in Montreal and Toronto. Few Canadian training 
programs—whether in geriatrics, oncology, or allied health 
programs—include formal teaching on geriatric oncology.
Attendees identified several challenges in delivering 
education in geriatric oncology. First, the field of geriatric 
oncology, and therefore the specific knowledge and skills 
that are unique to the field, are not currently well-defined. 
Second, because most experts in geriatric oncology are 
concentrated in a few centres, many centres do not have 
teachers with the expertise to deliver educational content in 
geriatric oncology. Lastly, attendees felt that further devel-
opment of the evidence base in geriatric oncology through 
ongoing research, scholarship, and clinical collaboration 
was necessary and critical to encourage and reinforce the 
need for geriatric oncology training.
To address those challenges, attendees identified 
several short- and long-term goals (Table iii). Defining 
key geriatric oncology competencies for each discipline 
was felt to be an essential initial step. Further, sharing 
available educational material and expertise in geriatric 
oncology through national collaborations by harnessing 
technology—in particular, leveraging currently available 
webinar series within geriatric medicine, oncology, and 
allied health disciplines—was felt to be a particularly 
favourable method of both providing education and pro-
moting the field of geriatric oncology. That approach could 
help programs without specific local expertise deliver 
educational content to their trainees. An important early 
step in disseminating such materials is a systematic online 
inventory and quality assessment of existing materials.
In the long term, attendees suggested that a geriatric 
oncology curriculum for oncologists, geriatricians, and al-
lied health professionals should be developed. Integration 
within the traditional curriculum and uptake of geriatric 
oncology topics into licensing exams would accelerate 
the knowledge of the workforce caring for older adults 
with cancer. Inter-professional workshops and certificate 
courses should be developed to educate clinicians and 
recognize those who have attained core geriatric oncology 
competencies and could be linked to other existing provin-
cial and national education venues for various clinicians. 
Future goals could also include development of a geriatric 
oncology fellowship, with the potential of applying for an 
official Royal College of Physicians and Surgeons of Canada 
designation as an Area of Focused Competence program.
Geriatric Oncology Clinical Care
The morning session to discuss the best model of care 
was moderated by Drs. Wendy Duggleby and Doreen 
Wan-Chow-Wah. In the afternoon, a session addressing 
barriers to the implementation of geriatric oncology in 
clinical practice was moderated by Drs. Etienne Brain and 
Camilla Wong.
Currently, there are few specialized geriatric oncology 
clinics in Canada. The geriatric oncology service at the 
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TABLE I List of attendees
Attendee Affiliation
Shabbir Alibhai University Health Network
Ewa Szumacher Sunnybrook Health Sciences Centre 
Tina Hsu The Ottawa Hospital Cancer Centre
Martine Puts University of Toronto
José Morais McGill University
Winson Cheung BC Cancer Agency
Doreen Wan-Chow-Wah McGill University
Francine Gaba Idiamey Centre Hospitalier de l’Universite de Montréal and the Jewish General Hospital
Rajin Mehta Sunnybrook Health Sciences Centre
Samir Sinha Mount Sinai Hospital
Barbara Liu Sunnybrook Health Sciences Centre
Carla Rosario University of Toronto
Karen Fruetel University of Calgary, Canadian Geriatrics Society
Mathilde Laferrière-Chevrefils Université de Montréal
Camilla Wong St. Michael’s Hospital
Marg Fitch University of Toronto
Antonio Vigano McGill University Health Centre
Flavia De Angelis Hôpital Charles-LeMoyne
Dominque Tremblay Hôpital Charles-LeMoyne
Caroline Mariano Royal Columbian Hospital
David Dawe Cancer Care Manitoba
Doris Howell University Health Network
Fay Strohschein McGill University
Carlo De Angelis Sunnybrook Health Sciences Centre
Soha Ahrari Sunnybrook Health Sciences Centre
Maureen Trudeau Sunnybrook Health Sciences Centre
Supriya Mohile University of Rochester Medical Center, U.S. Cancer and Aging Research Group
Craig Earle Cancer Care Ontario and the Ontario Institute for Cancer Research
Catalina Hernadez Torres The Ottawa Hospital Cancer Centre
Ines Menjak University of Toronto
Tanya Skamene Queen’s University
Daniel Yokom University Health Network
Allison Loucks University Health Network
Lisa Di Prospero Sunnybrook Health Sciences Centre
Julie Beaudoin Université Laval
Justin Lee Sunnybrook Health Sciences Centre
Wendy Duggleby University of Alberta
Tom Kouroukis McMaster University
Anca Prica University Health Network
Rena Buckstein Sunnybrook Health Sciences Centre
Michael Wortzman Canadian Cancer Society Research Institute
Janet McElhaney Institute of Aging, Canadian Institutes of Health Research, and Northern Ontario School of Medicine
Hyman Muss Lineberger Comprehensive Cancer Center, U.S. Cancer and Aging Research Group
Harriet Richardson Canadian Cancer Trials Group
Tamara Harth Sunnybrook Health Sciences Centre
Samar Toubasi University of Toronto
Schroder Sattar University of Toronto
Vida Ghodraty Jabloo University of Toronto
Manon Chevalier Université Laval
Christine Dionne Université Laval
Maia von Maltzahn University of Toronto
Etienne Brain Institut Curie, GERICO (French Geriatric Oncology) network
Lisa Johnson Amgen Oncology
Nancy Barr Amgen Oncology
CANADIAN NETWORK ON AGING AND CANCER: THE FIRST MEETING, Puts et al.
e166 Current Oncology, Vol. 24, No. 2, April 2017 © 2017 Multimed Inc.
Jewish General Hospital’s Segal Cancer Centre in Montreal, 
which started in 2006, is one of the most established geri-
atric oncology clinics in Canada. Its multidisciplinary 
team includes geriatrics, nursing, physical therapy, occu-
pational therapy, social work, pharmacy, neuropsychology, 
and nutrition. Other geriatric oncology clinics have been 
established in Quebec City and Toronto. Most attendees, 
however, reported no formal partnerships between geri-
atrics and oncology.
Numerous barriers were identified, including the low 
referral rate for eligible older adults. A solution identified 
was to use a geriatric screening tool as a strategy to identify 
older adults most likely to benefit. Furthermore, staffing of 
the clinic was challenging—namely, finding staff interested 
in geriatric oncology, and in smaller centres, lack of access 
to various health disciplines. Potential solutions identified 
were to use resources already available in the community to 
train more nurses and to leverage telemedicine technology 
to access geriatric expertise not available locally.
Participants felt that it was very important that geriat-
ric oncology care be integrated into the oncology clinical 
setting, with clinicians working together to share the infor-
mation gathered so that older adults need not see two sep-
arate services. It was agreed that an interested geriatrician 
has to partner with someone in oncology to ensure buy-in, 
support, and shared expertise. Key players in a geriatric 
oncology service are nurses and nurse navigators, who 
are essential to help assess older adults and navigate the 
cancer system and community health services, including 
palliative and other supportive care services. There is a 
need to engage key nurses in geriatrics in the development 
of a clinic. They were identified as key stakeholders because 
they can share expertise and facilitate removing and over-
coming organizational barriers.
An important component of oncologic care is multidis-
ciplinary tumour boards. Some existing geriatric oncology 
services noted that, although tumour boards can enhance 
visibility and provide a platform for the selection of older 
cancer patients requiring geriatric oncology expertise, the 
breadth of site-specific tumour boards that regularly meet 
makes such changes logistically challenging. A solution 
identified was to organize tumour boards so that patients 
TABLE II Program for the day
Time Session description
9h30–9h45 Welcome, opening remarks, goals of meeting (team)
9h45–10h00 Introductions
10h00–10h20 Canada’s aging population—where we are and where we’re going
How are aging and cancer connected? (Dr. Morais)
10h20–10h35 Coffee break
10h35–11h40 Current geriatric oncology research in Canada
10h35–10h45 Overview of the current landscape of research in geriatric assessment and management in older adults in Canada (Dr. Alibhai)
10h45–11h00 Survivorship research (Dr. Fitch)
11h00–11h15 Health services research (Dr. Cheung)
11h15–11h30 Clinical trials (Dr. Trudeau)
11h30–11h40 Question-and-answer period
11h40–12h05 The Cancer and Aging Research Group: how it started and lessons learned (Dr. Mohile)
12h05–12h30 The French organization of Geriatric Oncology and Related Research (Dr. Etienne Brain)
12h30–13h15 Lunch
13h15–14h00 Small-group breakouts
Participants attend one small-group discussion of 45 minutes
Best model of education (Discussion leaders: Drs. Hsu and Szumacher)
Best model of care (Discussion leaders: Drs. Duggleby and Wan-Chow-Wah)
Best model of research (Discussion leaders: Drs. Mariano and Alibhai)
14h00–14h45 Reconvene; review and discussion of issues discussed in small groups
14h45–15h00 Coffee break
15h00–15h45 Small-group breakouts
Participants attend one small group discussion of 45 minutes
Barriers to implementing geriatric oncology in clinical practice (Discussion leaders: Drs. Brain and Wong)
Barriers to geriatric oncology research (Discussion leaders: Drs. Trudeau and Muss)
Aims of the Canadian Network on Aging and Cancer and how to move forward (Discussion leaders: Drs. Mohile and Puts
15h45–16h15 Development of a Canadian geriatric collaborative network
16h15–16h30 Closing remarks (team)
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potentially requiring geriatric oncology input are grouped, 
allowing the geriatric oncology consultant to attend at a 
particular time to enhance efficiency.
Lastly, there was also ambiguity about the roles and 
responsibilities of the oncologist compared with the family 
physician in implementing recommendations from the 
geriatric oncology clinic; however, clear communication 
is key to addressing that ambiguity.
Another point of discussion was whether geriatric on-
cology and palliative care should be integrated or function 
as separate services. The discussion suggested that overlap 
exists, but that keeping them separate is important, be-
cause some of the issues are very different. Furthermore, 
the relationship between oncology and palliative care 
is complex, each having its own set of issues. Attendees 
considered it important to connect with palliative care 
in providing the service to older adults so as to enhance 
well-being while avoiding duplication of services.
Geriatric Oncology Research
Two small-group sessions with respect to research were 
held. The first was moderated by Drs. Caroline Mariano and 
Shabbir Alibhai. It focused on the best model of research. 
The second was moderated by Drs. Maureen Trudeau and 
Hyman Muss, and it focused on barriers to geriatric oncol-
ogy research. Throughout the meeting, it became apparent 
that many attendees were actively involved in geriatric 
oncology research, with even more attendees throughout 
Canada being interested in engaging in such research. 
Research interests included the use of existing databases 
and clinical trial datasets to examine age-related oncologic 
questions (for example, efficacy, toxicity, access), the value 
of geriatric assessment in clinical trials, and evaluations of 
the performance of geriatric screening tools (for example, 
the Vulnerable Elders Survey, G8) in clinics. There was a 
lot of positive energy in the room, and there was also a 
sense that we are at a critical juncture to move ahead with 
exciting research efforts in this field.
One challenge is the relatively limited and geographi-
cally dispersed expertise in geriatric oncology in Canada. 
The Network meeting was felt to be an important first step 
in addressing that challenge. Participants agreed that, to 
promote networking and collaborations, formal identifi-
cation and compilation of a list of Canadian researchers 
currently engaged in geriatric oncology research and their 
areas of interest should be a priority. The establishment of 
a national network to facilitate expert input on proposed 
studies (similar to carg in the United States) and the de-
velopment of collaborations with international trial groups 
were also identified as possible solutions.
One of the most important barriers was lack of ad-
equate resources (money and time). Solutions included 
leveraging all existing funding opportunities and raising 
awareness through education about the aging imperative to 
philanthropic, pharmaceutical, and peer-reviewed funders 
(for example, the Canadian Institutes of Health Research 
TABLE III Short-term and long-term priorities
Domain Priorities
Short-term (12 months) Long-term (5 years)
Education  ■ Increase awareness about geriatric oncology.
 ■  Create a national professional network with 
communication via e-mail or video conferencing (or both) 
to share educational materials.
 ■  Define core competencies that trainees should possess in 
geriatric oncology.
 ■  Develop a geriatric oncology curriculum for oncologists and 
geriatricians.
 ■  Incorporate a geriatric oncology curriculum into training 
(undergraduate, postgraduate, continuing education).
 ■  Consider applying for Area of Focused Competence status 
through the Royal College of Physicians and Surgeons of 
Canada.
Clinical  ■  Develop a consistent message (or “branding”) of what 
geriatric oncology is and why it is important clinically
 ■ Convey value of geriatric assessment to oncologists.
 ■  Establish care pathways to guide timing and 
appropriateness of referral to geriatric oncology.
 ■ Implement evidence-based geriatric oncology care.
 ■  Establish various clinical models based on local availability of 
human resources.
 ■  Identify and develop learning resources to teach geriatric 
assessment principles using standardized tools.
Research  ■  Compile a list of current geriatric oncology research in 
Canada.
 ■  Enter into dialogue with major cancer funding agencies 
(Canadian Institutes of Health Research, Canadian Cancer 
Society Research Institute) to enhance focus on geriatric 
oncology research through requests for proposals or other 
mechanisms, and highlight gaps in prior and current 
research.
 ■  Identify gaps in existing knowledge concerning drug 
safety and toxicity data for older adults that can be targets 
of secondary analyses of clinical studies or retrospective 
analyses of large drug databases.
 ■  Establish a network of experienced mentors and 
researchers who can serve as local and national resources 
to help others who are entering this field.
 ■  Establish elder-specific clinic trials through the Canadian 
Cancer Trials Group
 ■  Stimulate more randomized controlled trials of interventions 
that evaluate their effect on patient-reported outcomes such as 
functional status and quality of life.
 ■  Integrate geriatric oncology within existing research 
structures.
 ■  Add geriatric assessment into randomized controlled trials 
that are opening soon:
– Establish a geriatric oncology committee to vet trial pro-
posals coming through existing groups such as the Canadi-
an Cancer Trials Group.
– Ensure that new trial protocols include geriatric-specific 
measures both as predictor variables (geriatric assessment 
domains, toxicity prediction or frailty screening tools) and 
outcomes (for example, functional status, cognition).
– Disseminate best practices for recruiting older adults into 
clinical trials.
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and the Canadian Cancer Society Research Institute). In 
relation to those activities, the Network should explore 
opportunities to work with major peer-reviewed funding 
agencies to establish targeted calls or specific requests for 
proposals in the area of geriatric oncology.
A second key barrier was the challenges to participa-
tion in studies for older adults, because of dependency on 
others for transportation, financial barriers, language and 
literacy barriers, and physical and cognitive impairments. 
Solutions included maximizing flexibility in enrolment 
criteria and consulting with individuals having expertise 
in geriatric oncology or possibly even older adults with 
cancer themselves during the design phase to ensure 
studies are “elder friendly.” Another opportunity is to look 
at post-marketing surveillance or so-called phase iv stud-
ies using clinical or administrative databases to provide 
real-world effectiveness and toxicity data for older adults. 
A third option is to engage more with pharmaceutical 
companies and Health Canada to apply various pressures 
(from moral suasion to regulatory requirements) to ensure 
that adequate proportions of older adults are enrolled 
onto relevant registration trials. A central theme was the 
underrepresentation of older adults with cancer in current 
research, particularly clinical trials and mechanistic stud-
ies. Moreover, most of the existing research has been in 
medical oncology, and so gaps were even larger in surgical 
and radiation oncology.
With respect to future progress, four key ideas were put 
forward. First, the need to incorporate multiple methodolo-
gies and to consider a wide range of outcomes to fully study 
this complex field, incorporating qualitative studies and 
ensuring a focus on survivorship and other elder-relevant 
outcomes beyond traditional disease-based oncologic out-
comes such as progression-free survival and response rates.
Second, several aspects of research with older adults 
are not particularly clear and should be formally studied. 
For example, does it cost more to recruit older adults to 
trials? And what is the best way to make trials more “elder 
friendly”? Furthermore, how should researchers deal with 
ethics issues that arise when performing geriatric assess-
ments in older cancer patients (for example, the implica-
tions of diagnosing new cognitive impairment)?
Third, discussion ensued about the best methods for 
incorporating a standardized geriatric assessment across 
centres. The feeling was that, based on other jurisdictions, 
such standardization is not likely to happen quickly, nor 
is it a prerequisite to moving forward with incorporating 
geriatric assessments into trials and observational studies 
at baseline. Agreeing on common elements and identifying 
a few of the best tools (for example, the carg tools) is a rea-
sonable compromise. The choices should leverage existing 
datasets and collection methods where possible. For exam-
ple, the ways to link geriatric assessments with standardized 
point-of-care symptom assessment (for example, using the 
Edmonton Symptom Assessment System as mandated by 
agencies such as Cancer Care Ontario) should be explored, 
and various team members should be educated about how 
to best recruit and retain older adults in studies.
Finally, best practice in research should involve in-
terdisciplinary teams and collaborative models of care 
and research.
Development of a Canadian Geriatric Oncology 
Collaborative Network
The f inal discussion involved the large group and 
focused on a possible future Canadian collaborative 
network. This discussion was moderated by Drs. Su-
priya Mohile and Martine Puts. Most attendees whole-
heartedly agreed that a Canadian Network on Aging 
and Cancer is needed, because some issues in educa-
tion, clinical care, and research are unique to Canada. 
However, the Network should collaborate closely with 
existing networks such as carg, gerico, and others to 
move the geriatric oncology agenda forward worldwide 
and to build on the efforts of successful initiatives. Most 
interested centres have at least 1 representative, which 
is a good starting point and will make the network even 
more critical.
Logistically, it was felt that using an informal struc-
ture and connecting at regular intervals (monthly, for 
instance) in telephone conference calls or webinars to 
develop more collaboration across Canada, similar to 
the carg model, would work best. Interest was expressed 
in developing a shared Web site for the network, which 
would serve as a common assembly point where updates 
and news for all members could be disseminated and 
members could liaise. It was suggested that the group 
connect with local funding sources and pharmaceutical 
companies to obtain some initial funding to support the 
development of the Web site. Finally, the participants 
agreed on an initial set of goals and priorities, as sum-
marized in Table iv.
MEETING EVALUATION
Evaluation forms were circulated to all meeting attend-
ees and were returned by 29 attendees (57%). Of the 
respondents, 17% were geriatricians; 20% were medical 
oncologists; 6% were nurses, clinical nurse specialists, or 
nurse practitioners; 17% were doctoral researchers; 6% 
were radiation oncologists; 17% were residents or fellows; 
and 17% were in allied disciplines. Of the respondents, 
69% practiced in an academic teaching hospital, 12% in a 
comprehensive cancer centre, and 16% in a non-academic 
hospital; 3% were research administrators.
All respondents agreed or strongly agreed that attend-
ing the meeting was a good use of their time, with 63% 
considering the meeting excellent, and 37% considering 
it very good. All attendees agreed or strongly agreed that 
what they learned at the meeting was relevant to their 
clinical practice and would positively influence their fu-
ture research. When asked how the meeting would affect 
their clinical practice, respondents said that they felt more 
aware of the need to focus on geriatric oncology, were in-
terested in networking with other experts in the field, were 
considering implementing geriatric screening or assess-
ment, and were considering various strategies for initiat-
ing geriatric oncology research and clinics. When asked 
how the meeting would affect their research, attendees 
were interested in working collaboratively, focusing on 
older-adult clinical trials, and incorporating patient-cen-
tred outcomes into studies. For future meetings, many 
respondents suggested topics related to inpatient care. 
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They also wanted to hear more about specific research 
projects and how to design evidence-based clinical trials 
for the elderly. Respondents liked the organization of the 
meeting; however, they wished that there was more time 
for discussion and a clearer role for participants. Respon-
dents were interested in continuing to be involved in the 
Network online after the meeting and to participate in 
future meetings.
SUMMARY
Based on both the returned surveys and the informal 
feedback from participants, the meeting was successful in 
reaching its objectives of reviewing the current education, 
clinical, and research landscape in geriatric oncology in 
Canada; identifying issues of high priority, current bar-
riers, and possible solutions; and developing a network 
of investigators who are interested in improving health 
outcomes for older adults with cancer. Our next steps are 
to establish an informal network and a Web site for the 
group. In future, we hope to continue these meetings ev-
ery 1–2 years to advance the field and practice of geriatric 
oncology in Canada.
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TABLE IV Goals of the Canadian Network on Aging and Cancer
Goals
Short term Long term
1. To develop a mission statement 1. To develop ongoing opportunities for networking and to collabo-
rate on papers that speak about efforts by this network
2. To develop a national inventory of who is interested in geriatric 
oncology and what is currently being developed in the areas of 
education, research, and clinical care
2. To identify education, clinical, and research leaders interested in 
promoting geriatric oncology across Canada
3. To start monthly 1-hour teleconference calls open to anyone in-
terested
3. To develop mentoring strategies for clinicians, educators, and 
researchers interested in geriatric oncology
4. To connect with potential sponsors (Canadian Institutes of Health 
Research, cancer foundations, specialty groups, patient advocacy 
groups)
4. To foster collaboration on grants to develop shared projects to 
facilitate recruitment and develop expertise
5. To establish in-person meetings at other scientific conferences 
such as the American Society of Clinical Oncology, the Canadian 
Geriatrics Society, and so on
5. To organize the Canadian Network on Aging and Cancer by re-
gion (geographic, subspecialty) to facilitate networking at other 
meetings throughout the year
6. To connect with other groups such as surgical oncology to in-
crease collaborations and share resources
6. To leverage strengths from various sites through collaboration 
leading to a greater goal (for example, clinical expertise at one 
institution could help to inform and review priorities and to sup-
port research using help from research infrastructure at other sites)
7. To improve awareness about geriatric oncology by organizing 
workshops and sharing data to help develop collaborations and 
best clinical practice. To raise the profile of the Canadian Net-
work on Aging and Cancer by ensuring its involvement in presen-
tations at conferences.
8. To promote advocacy—for example, to acquire seats on major 
regional or national guideline committees (Canadian provincial 
cancer organizations, Canadian Cancer Research Alliance, for 
instance) to help as well as to connect with patient advocacy 
groups to reach out to patients themselves to advocate for geriat-
ric oncology
9. To identify permanent administrative support for the network, 
Web site, and e-mail messages
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